Literature DB >> 20694533

Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting.

Jana Cumova1, L Kovarova, A Potacova, I Buresova, F Kryukov, M Penka, J Michalek, R Hajek.   

Abstract

Plasma cells (PCs) enrichment from bone marrow samples of multiple myeloma (MM) patients is frequently performed by immunomagnetic separation (magnetic activated cell sorting, MACS) using anti-CD138 MicroBeads. The aim of our work was to find optimal strategy for immunomagnetic separation of PCs and determine optimal algorithm of separation techniques for samples with various percentage of neoplastic cells. From 2007 to 2008, selection of PCs using separation programs Possels and Posseld(2) was carried out on 234 bone marrow samples obtained from 208 MM patients. In 2008, an optimal algorithm for separation programs was introduced based on the analysis of the previous experiments. The Possels program is applicable for samples with >10% PCs in the mononuclear fraction, while the Posseld(2) program is used for samples with 5-10% PCs in the mononuclear fraction. Median purity of 92.6% for the positive fraction of cells (range 14.5-99.6%) and median recovery of 60.4% (range 25.7-99.5%) were obtained when the Possels program was applied (n = 45). A total of 80% (36/45) of processed samples had purity of >70%. Median purity for the positive fraction of 83.7% (range 14.3-99.7%) and median recovery of 14.3% (range 3.6-50.0%) were achieved using the Posseld(2) program (n = 99). A total of 68% (67/99) of processed samples reached >70% purity. This separation strategy enabled us to obtain sufficient amounts of highly purified PCs required for subsequent research purposes. The MACS method has been unsuccessful if the percentage of PCs in the initial sample was <5%. These samples were processed by fluorescence activated cell sorting (FACS).

Entities:  

Mesh:

Year:  2010        PMID: 20694533     DOI: 10.1007/s12185-010-0651-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

2.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

3.  A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.

Authors:  J Wijdenes; W C Vooijs; C Clément; J Post; F Morard; N Vita; P Laurent; R X Sun; B Klein; J M Dore
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

4.  The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.

Authors:  M Jourdan; M Ferlin; E Legouffe; M Horvathova; J Liautard; J F Rossi; J Wijdenes; J Brochier; B Klein
Journal:  Br J Haematol       Date:  1998-03       Impact factor: 6.998

5.  Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.

Authors:  J Drach; J Schuster; H Nowotny; J Angerler; F Rosenthal; M Fiegl; C Rothermundt; A Gsur; U Jäger; R Heinz
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

6.  Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility.

Authors:  Gregory J Ahmann; Wee Joo Chng; Kimberly J Henderson; Tammy L Price-Troska; Roberta W DeGoey; Michael M Timm; Angela Dispenzieri; Philip R Greipp; Alicia Sable-Hunt; Leif Bergsagel; Rafael Fonseca
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

7.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

8.  Cell Separation by Non-Inertial Force Fields in Microfluidic Systems.

Authors:  Hideaki Tsutsui; Chih-Ming Ho
Journal:  Mech Res Commun       Date:  2009-01-01       Impact factor: 2.254

Review 9.  International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Authors:  R Fonseca; P L Bergsagel; J Drach; J Shaughnessy; N Gutierrez; A K Stewart; G Morgan; B Van Ness; M Chesi; S Minvielle; A Neri; B Barlogie; W M Kuehl; P Liebisch; F Davies; S Chen-Kiang; B G M Durie; R Carrasco; Orhan Sezer; Tony Reiman; Linda Pilarski; H Avet-Loiseau
Journal:  Leukemia       Date:  2009-10-01       Impact factor: 11.528

10.  Genetics and cytogenetics of multiple myeloma: a workshop report.

Authors:  Rafael Fonseca; Bart Barlogie; Regis Bataille; Christian Bastard; P Leif Bergsagel; Marta Chesi; Faith E Davies; Johannes Drach; Philip R Greipp; Ilan R Kirsch; W Michael Kuehl; Jesus M Hernandez; Stephane Minvielle; Linda M Pilarski; John D Shaughnessy; A Keith Stewart; Herve Avet-Loiseau
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more
  11 in total

1.  Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.

Authors:  Shashirekha Shetty; Marion Siady; Kalyan C Mallempati; Andrew Wilson; Jeff Poarch; Brandon Chandler; Judy Gray; Mohamed E Salama
Journal:  Int J Hematol       Date:  2012-02-11       Impact factor: 2.490

2.  Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Authors:  Martin Schmidt-Hieber; María Laura Gutiérrez; Martin Pérez-Andrés; Bruno Paiva; Ana Rasillo; Maria Dolores Tabernero; José Maria Sayagués; Antonio Lopez; Paloma Bárcena; María Luz Sanchez; Norma C Gutiérrez; Jesus F San Miguel; Alberto Orfao
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

3.  Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.

Authors:  Jan Smetana; Jan Frohlich; Romana Zaoralova; Vladimira Vallova; Henrieta Greslikova; Renata Kupska; Pavel Nemec; Aneta Mikulasova; Martina Almasi; Ludek Pour; Zdenek Adam; Viera Sandecka; Lenka Zahradová; Roman Hajek; Petr Kuglik
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

4.  Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies.

Authors:  T Ševčíková; K Growková; Z Kufová; J Filipová; P Vrublová; T Jelínek; Z Kořístek; F Kryukov; E Kryukova; R Hájek
Journal:  J Clin Pathol       Date:  2017-03-30       Impact factor: 3.411

Review 5.  Dielectrophoresis for Biomedical Sciences Applications: A Review.

Authors:  Nurhaslina Abd Rahman; Fatimah Ibrahim; Bashar Yafouz
Journal:  Sensors (Basel)       Date:  2017-02-24       Impact factor: 3.576

6.  GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival.

Authors:  Daniela N Petrusca; Patrick L Mulcrone; David A Macar; Ryan T Bishop; Evgeny Berdyshev; Attaya Suvannasankha; Judith L Anderson; Quanhong Sun; Philip E Auron; Deborah L Galson; G David Roodman
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

7.  Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.

Authors:  J Teramachi; R Silbermann; P Yang; W Zhao; K S Mohammad; J Guo; J L Anderson; D Zhou; R Feng; K-Z Myint; N Maertz; J H Beumer; J L Eiseman; J J Windle; X-Q Xie; G D Roodman; N Kurihara
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

8.  Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.

Authors:  Jan Smetana; Jan Oppelt; Martin Štork; Luděk Pour; Petr Kuglík
Journal:  Mol Cytogenet       Date:  2018-01-18       Impact factor: 2.009

9.  Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma.

Authors:  Cristina Mansilla; Elena Soria; Miren Vallejo; Alberto Valiente; Aránzazu Perez-Juana; Amaya Zabalza; Guillermina Hurtado; Francisco Sala; Natalia Ramírez
Journal:  Transl Oncol       Date:  2018-03-30       Impact factor: 4.243

10.  Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.

Authors:  Daniela N Petrusca; Denise Toscani; Feng-Ming Wang; Cheolkyu Park; Colin D Crean; Judith L Anderson; Silvia Marino; Khalid S Mohammad; Dan Zhou; Rebecca Silbermann; Quanhong Sun; Noriyoshi Kurihara; Deborah L Galson; Nicola Giuliani; G David Roodman
Journal:  J Hematol Oncol       Date:  2018-10-04       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.